COMPANY
Affect Therapeutics, Inc.
Affect Therapeutics, Inc. is listed on ClinicalTrials.gov as the lead sponsor of 2 studies; the most recently updated is “Demonstration of a Digital Care Program for Methamphetamine Use Disorder” (no phase, completed), in Methamphetamine Abuse. Affect Therapeutics, Inc. has received NIH funding, most recently in fiscal 2021 for the project “Demonstration of a Digital Care Program for Methamphetamine Use Disorder”. From public records Source · Oct 12, 2026